Insights

Longevity and Health Fauna Bio focuses on translating extreme mammalian biology into therapeutics for disease prevention and aging-related health, presenting opportunity to position joint programs in obesity, heart disease, and longevity with potential pharma partners and contract research organizations.

AI and Data Launched Fauna Brain AI platform and Centaur knowledge graph to map gene-phenotype relationships, enabling faster target identification and data-driven partnering discussions with biotech and pharma companies seeking efficient drug target discovery.

Strategic Partnerships Recent exposure at BIO International Convention and growth through Series A funding indicate readiness for collaborations, licensing deals, and co-development opportunities with larger biotechs and specialty pharma looking to expand CNS, metabolic, and aging-focused pipelines.

Technology Stack Utilizes cloud, ML, and visualization tools (AWS, Cloudflare, Neo4j, and related web technologies) that can support scalable data platforms for potential collaborators requiring robust data integration, secure hosting, and compliant research infrastructure.

Growth and Investment Funding activity with a $40M Series A and ongoing revenue in the multi-million range signals a scalable partner for early-stage collaboration deals, sponsored research, or milestone-based licensing arrangements in translational therapeutics.

Fauna Bio Tech Stack

Fauna Bio uses 8 technology products and services including html5media, Amazon Web Services, jsDelivr, and more. Explore Fauna Bio's tech stack below.

  • html5media
    Audio, Video, Graphics
  • Amazon Web Services
    Cloud Hosting
  • jsDelivr
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Google Domains
    Domain Name Services
  • Slick
    Javascript Libraries
  • HSTS
    Security
  • Adobe Fonts
    Web Fonts

Media & News

Fauna Bio's Email Address Formats

Fauna Bio uses at least 1 format(s):
Fauna Bio Email FormatsExamplePercentage
First@faunabio.comJohn@faunabio.com
56%
FLast@faunabio.comJDoe@faunabio.com
30%
First.Last@faunabio.comJohn.Doe@faunabio.com
8%
Last@faunabio.comDoe@faunabio.com
6%

Frequently Asked Questions

What is Fauna Bio's official website and social media links?

Minus sign iconPlus sign icon
Fauna Bio's official website is faunabio.com and has social profiles on LinkedInCrunchbase.

What is Fauna Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Fauna Bio's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fauna Bio have currently?

Minus sign iconPlus sign icon
As of July 2026, Fauna Bio has approximately 22 employees across 1 continents, including North America. Key team members include Chief Technology Officer: L. B.Owner: L. H. N.Director Of Emerging Animal Models: B. S.. Explore Fauna Bio's employee directory with LeadIQ.

What industry does Fauna Bio belong to?

Minus sign iconPlus sign icon
Fauna Bio operates in the Biotechnology Research industry.

What technology does Fauna Bio use?

Minus sign iconPlus sign icon
Fauna Bio's tech stack includes html5mediaAmazon Web ServicesjsDelivrCloudflareGoogle DomainsSlickHSTSAdobe Fonts.

What is Fauna Bio's email format?

Minus sign iconPlus sign icon
Fauna Bio's email format typically follows the pattern of First@faunabio.com. Find more Fauna Bio email formats with LeadIQ.

How much funding has Fauna Bio raised to date?

Minus sign iconPlus sign icon
As of July 2026, Fauna Bio has raised $9M in funding. The last funding round occurred on Oct 21, 2021 for $9M.

When was Fauna Bio founded?

Minus sign iconPlus sign icon
Fauna Bio was founded in 2018.
Fauna Bio logo

Fauna Bio

Biotechnology ResearchCalifornia, United States11-50 Employees

Fauna Bio is a Berkeley, California-based biotechnology research company focused on non-model organism biology to uncover protective mammalian traits. It seeks to translate those natural insights into novel therapeutics aimed at preventing disease and addressing age-related health decline in humans. The firm operates with a small to mid-sized team at the crossroads of evolutionary biology and translational medicine.

Its primary customers are researchers and drug developers pursuing new therapies and drug targets for human diseases. In 2025, the company introduced Fauna Brain, an AI platform intended to speed up identification of promising targets for drug development.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $9M

    Fauna Bio has raised a total of $9M of funding over 4 rounds. Their latest funding round was raised on Oct 21, 2021 in the amount of $9M.

  • $10M$25M

    Fauna Bio's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $9M

    Fauna Bio has raised a total of $9M of funding over 4 rounds. Their latest funding round was raised on Oct 21, 2021 in the amount of $9M.

  • $10M$25M

    Fauna Bio's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.